Cargando…
Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity
It is well known that natural products are a rich source of compounds for applications in medicine, pharmacy, and biology. However, the exact molecular mechanisms of natural agents in human health have not been clearly defined. Here, we demonstrate for the first time that the polyphenolic phytoalexi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304512/ https://www.ncbi.nlm.nih.gov/pubmed/22423322 http://dx.doi.org/10.1038/srep00314 |
_version_ | 1782226906182057984 |
---|---|
author | Hagiwara, Keitaro Kosaka, Nobuyoshi Yoshioka, Yusuke Takahashi, Ryou-u Takeshita, Fumitaka Ochiya, Takahiro |
author_facet | Hagiwara, Keitaro Kosaka, Nobuyoshi Yoshioka, Yusuke Takahashi, Ryou-u Takeshita, Fumitaka Ochiya, Takahiro |
author_sort | Hagiwara, Keitaro |
collection | PubMed |
description | It is well known that natural products are a rich source of compounds for applications in medicine, pharmacy, and biology. However, the exact molecular mechanisms of natural agents in human health have not been clearly defined. Here, we demonstrate for the first time that the polyphenolic phytoalexin resveratrol promotes expression and activity of Argonaute2 (Ago2), a central RNA interference (RNAi) component, which thereby inhibits breast cancer stem-like cell characteristics by increasing the expression of a number of tumour-suppressive miRNAs, including miR-16, -141, -143, and -200c. Most importantly, resveratrol-induced Ago2 resulted in a long-term gene silencing response. We also found that pterostilbene, which is a natural dimethylated resveratrol analogue, is capable of mediating Ago2-dependent anti-cancer activity in a manner mechanistically similar to that of resveratrol. These findings suggest that the dietary intake of natural products contributes to the prevention and treatment of diseases by regulating the RNAi pathway. |
format | Online Article Text |
id | pubmed-3304512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-33045122012-03-15 Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity Hagiwara, Keitaro Kosaka, Nobuyoshi Yoshioka, Yusuke Takahashi, Ryou-u Takeshita, Fumitaka Ochiya, Takahiro Sci Rep Article It is well known that natural products are a rich source of compounds for applications in medicine, pharmacy, and biology. However, the exact molecular mechanisms of natural agents in human health have not been clearly defined. Here, we demonstrate for the first time that the polyphenolic phytoalexin resveratrol promotes expression and activity of Argonaute2 (Ago2), a central RNA interference (RNAi) component, which thereby inhibits breast cancer stem-like cell characteristics by increasing the expression of a number of tumour-suppressive miRNAs, including miR-16, -141, -143, and -200c. Most importantly, resveratrol-induced Ago2 resulted in a long-term gene silencing response. We also found that pterostilbene, which is a natural dimethylated resveratrol analogue, is capable of mediating Ago2-dependent anti-cancer activity in a manner mechanistically similar to that of resveratrol. These findings suggest that the dietary intake of natural products contributes to the prevention and treatment of diseases by regulating the RNAi pathway. Nature Publishing Group 2012-03-15 /pmc/articles/PMC3304512/ /pubmed/22423322 http://dx.doi.org/10.1038/srep00314 Text en Copyright © 2012, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareALike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Article Hagiwara, Keitaro Kosaka, Nobuyoshi Yoshioka, Yusuke Takahashi, Ryou-u Takeshita, Fumitaka Ochiya, Takahiro Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity |
title | Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity |
title_full | Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity |
title_fullStr | Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity |
title_full_unstemmed | Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity |
title_short | Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity |
title_sort | stilbene derivatives promote ago2-dependent tumour-suppressive microrna activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304512/ https://www.ncbi.nlm.nih.gov/pubmed/22423322 http://dx.doi.org/10.1038/srep00314 |
work_keys_str_mv | AT hagiwarakeitaro stilbenederivativespromoteago2dependenttumoursuppressivemicrornaactivity AT kosakanobuyoshi stilbenederivativespromoteago2dependenttumoursuppressivemicrornaactivity AT yoshiokayusuke stilbenederivativespromoteago2dependenttumoursuppressivemicrornaactivity AT takahashiryouu stilbenederivativespromoteago2dependenttumoursuppressivemicrornaactivity AT takeshitafumitaka stilbenederivativespromoteago2dependenttumoursuppressivemicrornaactivity AT ochiyatakahiro stilbenederivativespromoteago2dependenttumoursuppressivemicrornaactivity |